July 2020
WASHINGTON, D.C. — U.S. Senator Debbie Stabenow (MI) and Chairwoman of the House Oversight Committee Carolyn B. Maloney (NY-12) asked the Government Accountability Office (GAO) to investigate the discovery and development remdesivir – the first drug authorized to treat COVID-19. Gilead, the company that owns the drug, collected more than $22.4 billion in total revenue and generated more than $5.3 billion in profit last year.
Washington, D.C. (July 24, 2020)— Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after President Donald Trump released Executive Orders on drug pricing:
Washington, D.C. (July 24, 2020)—Today, Rep. Harley Rouda, Chairman of the Subcommittee on Environment, held a hybrid hearing featuring testimony from Federal Emergency Management Agency (FEMA) Administrator Peter T.
Washington, D.C. – Today, the Inspectors General (IG) of the Department of Justice (DOJ) and Department of Homeland Security (DHS) announced they will both launch investigations into the Trump Administration's use of violent tactics against peaceful protestors in Washington D.C., Portland, Oregon, and elsewhere around the country.
Washington, D.C. (July 23, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep. Nydia M.
Washington, D.C. (June 23, 2020)— Today, Rep. Stephen F. Lynch, Chairman of the Subcommittee on National Security, held a hybrid hearing to examine the Trump Administration's implementation of the United States Strategy on Women, Peace, and Security (WPS Strategy).
Washington, D.C. (July 23, 2020)—This week, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, held a hybrid hearing to examine Lockheed Martin's failure to deliver spare parts for the F-35 Joint Strike Fighter that were ready for installation.